Search research articles
Contact Us
Filters
Showing results (51-60 of 189) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2014
Galeterone prevents androgen receptor binding to chromatin and enhances degradation of mutant androgen receptor
Ziyang Yu, Changmeng Cai, Shuai Gao, et al.
Cancer Research
|
January 20, 2007
SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells
Hongyun Wang, Nicole C McKnight, Tao Zhang, et al.
European Journal of Immunology
|
December 30, 2009
The A2aR adenosine receptor controls cytokine production in iNKT cells
Michael Nowak, Lydia Lynch, Simon Yue, et al.
Cell Reports
|
April 12, 2026
Wntless degradation mediated by CaMKII inhibition drives endoplasmic reticulum stress and apoptosis
Zhongkai Gu, Jude Owiredu, Betul Ersoy-Fazlioglu, et al.
The Journal of Biological Chemistry
|
September 8, 2007
Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer cells
Xinnong Jiang, Robert A Borgesi, Nicole C McKnight, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 23, 2010
Recognition of Cluster of Differentiation 1 Antigens by Human CD4-CD8- CytolyticT Lymphocyte. Nature. 1989. 341: 447-450. 1989
Steven Porcelli, Michael B Brenner, Julia L Greenstein, et al.
The Journal of Biological Chemistry
|
January 12, 2013
SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer
Hongyun Wang, Lingfeng He, Fen Ma, et al.
Molecular and Cellular Biology
|
January 24, 2006
Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction
Shao-Yong Chen, Gerburg Wulf, Xiao Zhen Zhou, et al.
Oncotarget
|
April 25, 2015
Loss of Wave1 gene defines a subtype of lethal prostate cancer
Adam G Sowalsky, Rebecca Sager, Rachel J Schaefer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 2, 2007
Exploiting regulatory T-cell populations for the immunotherapy of cancer
Hans J J van der Vliet, Henry B Koon, Michael B Atkins, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 189) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2014
Galeterone prevents androgen receptor binding to chromatin and enhances degradation of mutant androgen receptor
Ziyang Yu, Changmeng Cai, Shuai Gao, et al.
Cancer Research
|
January 20, 2007
SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells
Hongyun Wang, Nicole C McKnight, Tao Zhang, et al.
European Journal of Immunology
|
December 30, 2009
The A2aR adenosine receptor controls cytokine production in iNKT cells
Michael Nowak, Lydia Lynch, Simon Yue, et al.
Cell Reports
|
April 12, 2026
Wntless degradation mediated by CaMKII inhibition drives endoplasmic reticulum stress and apoptosis
Zhongkai Gu, Jude Owiredu, Betul Ersoy-Fazlioglu, et al.
The Journal of Biological Chemistry
|
September 8, 2007
Activation of nonreceptor tyrosine kinase Bmx/Etk mediated by phosphoinositide 3-kinase, epidermal growth factor receptor, and ErbB3 in prostate cancer cells
Xinnong Jiang, Robert A Borgesi, Nicole C McKnight, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 23, 2010
Recognition of Cluster of Differentiation 1 Antigens by Human CD4-CD8- CytolyticT Lymphocyte. Nature. 1989. 341: 447-450. 1989
Steven Porcelli, Michael B Brenner, Julia L Greenstein, et al.
The Journal of Biological Chemistry
|
January 12, 2013
SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer
Hongyun Wang, Lingfeng He, Fen Ma, et al.
Molecular and Cellular Biology
|
January 24, 2006
Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction
Shao-Yong Chen, Gerburg Wulf, Xiao Zhen Zhou, et al.
Oncotarget
|
April 25, 2015
Loss of Wave1 gene defines a subtype of lethal prostate cancer
Adam G Sowalsky, Rebecca Sager, Rachel J Schaefer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 2, 2007
Exploiting regulatory T-cell populations for the immunotherapy of cancer
Hans J J van der Vliet, Henry B Koon, Michael B Atkins, et al.
Page
of 19